DD vs TERN
Dupont De Nemours Inc (DD) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
DD currently screens at market cap $19.61B and trailing P/E 127.4. TERN currently screens at market cap $6.12B.
Not investment advice. Open the DD and TERN stock pages for the full models.
Not investment advice.